Neurol Clin Pract. 2013 Aug;3(4):288-294.

Postmarketing adverse drug reactions: A duty to report?

Klein E, Bourdette D.

Source

Department of Neurology (EK, DB), Oregon Health & Science University; Neurology Service (EK, DB), Department of Veterans Affairs Medical Center; and MS Center of Excellence-West (DB), Department of Veterans Affairs Medical Center, Portland, OR.

Abstract

Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.